Literature DB >> 12821390

Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma.

M C Quilty1, W P Gai, D L Pountney, A K West, J C Vickers.   

Abstract

Genetic and protein studies have indicated abnormalities in alpha-synuclein in neurodegenerative diseases. However, the developmental localization and cellular role of synuclein isoforms is contentious. We investigated the cellular localization of alpha-, beta-, and gamma-synuclein in developing cultured rat neurons and following axonal transection of relatively mature neurons, a model that disrupts the axonal cytoskeleton and results in regenerative sprouting. Cortical neurons were grown up to 21 days in vitro (DIV). Axon bundles at 21 DIV were transected and cellular changes examined at 4 and 24 h post-injury. Immunohistochemistry demonstrated that alpha- and beta-synuclein were localized to cellular cytosol and growth cones at 3DIV, with accumulating puncta-like labeling within axons and growth cones by 10-21DIV. In contrast, gamma-synuclein immunoreactivity was limited at all time points. By 21DIV, alpha- and beta-synuclein were present in the same neurons but largely in separate subregions, only 26% of puncta contained both alpha- and beta-synuclein immunoreactivity. Less than 20% of alpha-, beta-, and pan-synuclein immunoreactive puncta directly colocalized to synaptophysin profiles at 10DIV, decreasing to 10% at 21DIV. Both alpha- and beta-synuclein accumulated substantially within damaged axons at 21DIV and were localized to cytoskeletal abnormalities. At latter time points post-injury, alpha- and beta-synuclein immunoreactive puncta were localized to growth cone-like structures in regenerating neurites. This study shows that alpha- and beta-synuclein have a precise localization within cortical neurons and are generally nonoverlapping in their distribution within individual neurons. In addition, synuclein proteins accumulate rapidly in damaged axons and may have a role in regenerative sprouting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821390     DOI: 10.1016/s0014-4886(03)00108-0

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Examination of axonal injury and regeneration in micropatterned neuronal culture using pulsed laser microbeam dissection.

Authors:  Amy N Hellman; Behrad Vahidi; Hyung Joon Kim; Wael Mismar; Oswald Steward; Noo Li Jeon; Vasan Venugopalan
Journal:  Lab Chip       Date:  2010-06-09       Impact factor: 6.799

2.  NACP-Rep1 relates to Beck Depression Inventory scores in healthy humans.

Authors:  Bernd Lenz; Christiane Sysk; Norbert Thuerauf; Marion Clepce; Karin Reich; Helge Frieling; Georg Winterer; Stefan Bleich; Johannes Kornhuber
Journal:  J Mol Neurosci       Date:  2011-01-27       Impact factor: 3.444

3.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

4.  α-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia.

Authors:  Erik Su; Michael J Bell; Stephen R Wisniewski; P David Adelson; Keri L Janesko-Feldman; Rosanne Salonia; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır
Journal:  Dev Neurosci       Date:  2010-12-02       Impact factor: 2.984

Review 5.  Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.

Authors:  Dean L Pountney; Nicolas H Voelcker; Wei Ping Gai
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome.

Authors:  Arthur P Chou; Nigel Maidment; Rebecka Klintenberg; John E Casida; Sharon Li; Arthur G Fitzmaurice; Pierre-Olivier Fernagut; Farzad Mortazavi; Marie-Francoise Chesselet; Jeff M Bronstein
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

7.  Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edith Schreiner; Robert Wronski
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

9.  Molecular cloning, characterization and developmental expression of porcine beta-synuclein.

Authors:  Knud Larsen; Pernille Munk Frandsen; Lone Bruhn Madsen; Christian Bendixen
Journal:  Mol Biol Rep       Date:  2009-04-03       Impact factor: 2.316

10.  {alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics.

Authors:  Vítor L Sousa; Serena Bellani; Maila Giannandrea; Malikmohamed Yousuf; Flavia Valtorta; Jacopo Meldolesi; Evelina Chieregatti
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.